Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbCellera
AbCellera
Rallybio, AbCellera partner to develop therapeutics for rare diseases
Pharmaceutical Business Review
Fri, 12/2/22 - 10:54 am
Rallybio
AbCellera
Rare Diseases
drug discovery
A year after embarking on a new HQ and manufacturing site, AbCellera starts second phase of its buildout
Endpoints
Wed, 09/21/22 - 10:26 am
AbCellera
Canada
Versant partners with AbCellera to arm startups with better antibodies
BioPharma Dive
Wed, 07/27/22 - 10:45 am
AbCellera
Versant Ventures
antibodies
drug development
Looking for the next mRNA breakthrough, Moderna taps AbCellera in mysterious antibody discovery deal
Endpoints
Wed, 09/15/21 - 10:50 am
Moderna Therapeutics
AbCellera
MRNA
antibody discovery
drug discovery
With the ground broken on a Vancouver headquarters, antibody maker AbCellera will add manufacturing space next door
Endpoints
Fri, 06/25/21 - 11:02 am
Canada
Vancouver
AbCellera
innovation
AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation
Fierce Biotech
Mon, 12/7/20 - 10:37 am
AbCellera
Eli Lilly
R&D
Canada
COVID-19
antibodies
IPOs
Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
Endpoints
Thu, 11/19/20 - 10:21 am
AbCellera
Eli Lilly
Regeneron
Trianni
monoclonal antibodies
Lilly offers first evidence that its antibody drug may help treat COVID-19
BioPharma Dive
Wed, 09/16/20 - 10:59 am
Eli Lilly
AbCellera
antibodies
COVID-19
clinical trial
AbCellera acquires OrthoMab bispecific platform from Dualogics
Pharmaceutical Business Review
Fri, 08/21/20 - 12:01 pm
AbCellera
OrthoMab
bispecific antibodies
Dualogics
The money keeps coming for Eli Lilly COVID-19 partner AbCellera with $105M round
Fierce Biotech
Wed, 05/27/20 - 10:55 am
AbCellera
funding
COVID-19
Eli Lilly
Lilly-partnered AbCellera gets COVID-19 boost from Canadian government
Fierce Biotech
Mon, 05/4/20 - 10:56 am
Eli Lilly
AbCellera
Canada
COVID-19
antibodies
AbCellera and Lilly Slash Antibody Selection Time for COVID-19 With AI/Machine Learning
BioSpace
Tue, 04/28/20 - 11:43 pm
AbCellera
Eli Lilly
antibodies
COVID-19
artificial intelligence
machine learning
Eli Lilly teams with NIH, antibody upstart AbCellera in coronavirus hunt
Endpoints
Fri, 03/13/20 - 10:57 am
Eli Lilly
NIH
AbCellera
coronaviruses
COVID-19
vaccines
R&D
Novartis inks 10-target antibody discovery deal with AbCellera
Fierce Biotech
Thu, 02/14/19 - 09:45 am
Novartis
R&D
antibodies
AbCellera
Teva Shareholders Shrug Off Latest Collaborative Research Agreement
Yahoo/Benzinga
Wed, 02/3/16 - 08:43 am
Teva Pharmaceutical
shareholders
R&D
AbCellera
monoclonal antibodies
Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies
Yahoo
Tue, 02/2/16 - 01:27 pm
Teva Pharmaceutical
AbCellera
monoclonal antibodies